Uterine Suction

for surgical abortion

Treatment
Treatment
  • PREVENTION
  • DIAGNOSTIC
  • TREATMENT
  • OVERVIEW
  • TECHNOLOGY Characteristics
  • Uterine Suction
    Representative Product

    GLOBAL ANNUAL DEATHS ASSOCIATED WITH COMPLICATIONS OF ABORTION

    PERCENT (%)
    NUMBER

    Maternal

    5%
    13,000

    Neonatal

    N/A
    N/A

    Stillbirth

    N/A
    N/A

    Condition
    Roughly 50 million abortions occur annually. Uterine evacuation is the most common surgical method for abortion. Uterine suction is also used to treat molar pregnancy, endometrial biopsy, incomplete abortion, miscarriage, and retained products of conception--each of which can be dangerous to the mother.

    Mechanism of Action
    Abortion can be induced with a drug, introduction of intra- or extra-amniotic substances, or surgically. Surgical methods include dilation and curettage (D&C), and vacuum aspiration. D&C often requires heavy sedation or general anesthesia and involves the dilation of the cervix and scraping of the inner walls of the uterus. The WHO recommends that vacuum aspiration replace D&C.

     

    Vacuum aspiration can be done under local anesthesia and is typically performed on an outpatient basis in less than 15 minutes. After numbing the cervix, the practitioner inserts a lubricated, sterile plastic cannula into the uterus and connects it to a manual or electric vacuum source which empties the uterine contents. Up to 12 weeks from conception, dilation may not be required. Later abortions often require dilation and larger cannulae.

    Current Use in High-Resource Settings
    In 2005 in the US, about 87% of the 1.2M abortions were performed surgically, the majority using electric or manual vacuum aspiration. The average cost for the procedure was $413 in the US.

    Application in Low-Resource Settings
    Manual vacuum aspiration (MVA) has reduced the cost, skill requirements, and infrastructure needs of safe surgical abortion across the developing world. Unlike D&C, which may require a physician, MVA can be performed by midwives and nurses as an outpatient procedure. It does not require electricity, and has relatively low capital costs. As a result, the technology has had relatively high penetration across the developing world, and is now the standard of care in many settings where safe abortion was previously inaccessible. There are at least 8 manufacturers around the world providing MVA technology, varying in cost and quality. As the devices are often re-used, the best models are durable after multiple autoclave cycles (or other sterilization), and support interchangeable cannulae over a range of diameters from about 4mm to 12mm.
     

    REPRESENTATIVE DEVICES

    MAKE
    MODEL
    PRICE
    TECH
    STATUS
    NOTES

    Berkeley

    Synevac 10
    $3,000
    Electric Vacuum
    Marketed
    Most common EVA device

    Various

    Curettage Set
    $225**
    D&C
    Marketed
    High skill requirements

    Ipas

    MVA Plus Kit
    $30
    Manual Vacuum
    Marketed
    Single valve system

    MedGyn

    MVA Kit
    $6
    Manual Vacuum
    Marketed
    No valve system

    *Prices are approximated. Actual pricing can, and will vary by marketplace and market conditions. **Second hand kit

  • CHARACTERISTICS OF REPRESENTATIVE PRODUCT

    TECHNOLOGY CHARACTERISTICS

    OPERATIONAL PARAMETERS

    POTENTIAL OPPORTUNITIES FOR IMPROVEMENT

    SKILLS

    REQUIRED

    Intended end user
    Training required
    Time required per use
    Physician, Nurse
    Hours
    Minutes

    Users report that the language on MVA instructions is sometimes too advanced for mid-level practitioners. A more user friendly instruction set may be helpful.

    ENVIRONMENT/ INFRASTRUCTURE

    Power required
    Waste collection
    Complementary technologies required
    Temperature and storage
    Maintenance
    None
    Biohazard
    Speculum, gloves, local anesthetic, antiseptic wipes
    N/A
    Cleaning & sterilization key

    COST

    Device Cost (Approx)
    Cost/course (Approx)
    $20 - $40
    <$1 (sterilization)

    Private sector distribution of this device can be limited as it is low cost, low margin and low volume.

    OTHER

    Portability
    Regulatory
    Efficacy
    <250g
    Proven equivalence to electric aspiration (EVA), often with >99% efficacy

    Additional devices required for impact: N/A

Sources: Practical Guide for the Selection of MVA Instruments. EngenderHealth. 2003. RK Jones et al., Abortion in the United States: incidence and access to services, 2005, Perspectives on Sexual and Reproductive Health, 2008, 40(1):6–16. K Rogo. Improving technologies to reduce abortion-related morbidity and mortality. Intl J of Gyn &Obstetrics. Vol 85: S1, 2004, S73-S82 RK Jones et al, Characteristics of U.S. Abortion Patients, 2008, New York: Guttmacher Institute, 2010. Say L, Brahmi D, Kulier R, Campana A, Gülmezoglu AM. Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD003037. DOI: 10.1002/14651858.CD003037.pub2.